Comparison of quantitative sensory testing and heart rate variability in Swedish Val30Met ATTR

References

• Gene Review− NCBI bookshelf [Internet]. Familial Transthyretin; November 5, 2001 [cited 2010 April 04]; Available from: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=tfap
   Google Scholar
• Richardson SJ, Cody V, editors. Recent advances in Transthyretin evolution, structure and biological functions. Berlin Heidelberg: Springer-Verlag; 2009.
   Google Scholar
• Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54–69.
   PubMed Web of Science ®Google Scholar
• Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants. Amyloid 2003;10:160–184.
   PubMed Web of Science ®Google Scholar
• Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057–1062.
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: Geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288–294.
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512–521.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto Met al, Study group for hereditary neuropathy in Japan Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: Early- vs late-onset form. Arch Neurol 2002;59:1771–1776.
   PubMed Web of Science ®Google Scholar
• Conceição I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): Comparison between late- and early-onset cases in Portugal. Muscle Nerve 2007;35:116–118.
   PubMed Web of Science ®Google Scholar
• Koike H, Kawagashira Y, Iijima M, Yamamoto M, Hattori N, Tanaka F, Hirayama M, et al. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 2008;255:1526–1533.
   PubMed Web of Science ®Google Scholar
• Koike H, Ando Y, Ueda M, Mitsuharu U, Kawagashira Y, Iiijima M, Fujitake J, et al. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178–184.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113–1116.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, Uchino M, Suhr OB. Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients’ survival. Liver Transpl 2009;15:1229–1235.
   PubMed Web of Science ®Google Scholar
• Kimura J, editor. Electrodiagnostics in diseases of nerve and muscle: Principles and practice, 3rd ed. New York: Oxford University Press; 2001.
   Google Scholar
• Heldestad V, Nordh E. Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy. Muscle Nerve 2007;35:189–195.
   PubMed Web of Science ®Google Scholar
• Gruener G, Dyck PJ. Quantitative sensory testing: Methodology, applications, and future directions. J Clin Neurophysiol 1994;11:568–583.
   PubMed Web of Science ®Google Scholar
• Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898–904.
   PubMed Web of Science ®Google Scholar
• Levy D, Abraham R, Reid G. A comparison of two methods for measuring thermal thresholds in diabetic neuropathy. J Neurol Neurosurg Psychiatr 1989;52:1072–1077.
   PubMedGoogle Scholar
• Heldestad V, Linder J, Sellersjö L, Nordh E. Reproducibility and influence of test modality order on thermal perception and thermal pain thresholds in quantitative sensory testing. Clin Neurophysiol 2010;121:1878–1885.
   PubMed Web of Science ®Google Scholar
• Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998;5:288–300.
   PubMed Web of Science ®Google Scholar
• Kinoshita O, Hongo M, Saikawa Y, Katsuyama T, Tanaka M, Takeda M, Yamamoto H, et al. Heart rate variability in patients with familial amyloid polyneuropathy. Pacing Clin Electrophysiol 1997;20:2949–2953.
   PubMed Web of Science ®Google Scholar
• Schmidt R.F, editor. Fundamentals of sensory physiology, 3rd ed. New York Heidelberg-Berlin: Springer–Verlag; 1987. pp 102–110.
   Google Scholar
• Schmidt R.F, Thews G, editors. Human Physiology. New York Heidelberg-Berlin: Springer–Verlag; 1983. pp 111–127.
   Google Scholar
• Hilz MJ, Stemper B, Axelrod FB, Kolodny EH, Neundörfer B. Quantitative thermal perception testing in adults. J Clin Neurophysiol 1999;16:462–471.
   PubMed Web of Science ®Google Scholar
• Aberg M, Ljungberg C, Edin E, Jenmalm P, Millqvist H, Nordh E, Wiberg M. Considerations in evaluating new treatment alternatives following peripheral nerve injuries: A prospective clinical study of methods used to investigate sensory, motor and functional recovery. J Plast Reconstr Aesthet Surg 2007;60:103–113.
   PubMedGoogle Scholar
• Wiklund U, Hörnsten R, Olofsson BO, Suhr OB. Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy. Auton Neurosci 2010;156:124–130.
   PubMed Web of Science ®Google Scholar
• Coimbra A, Andrade C. Familial amyloid polyneuropathy: An electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes. Brain 1971;94:207–212.
   PubMedGoogle Scholar
• Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216:253–261.
   PubMed Web of Science ®Google Scholar
• Kim DH, Zeldenrust SR, Low PA, Dyck PJ. Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy. Muscle Nerve 2009;40:363–370.
   PubMed Web of Science ®Google Scholar
• Gutrecht JA. Sympathetic skin response. J Clin Neurophysiol 1994;11:519–524.
   PubMedGoogle Scholar
• Conceição IM, Castro JF, Scotto M, de Carvalho M. Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes. Clin Neurophysiol 2008;119:1082–1087.
   PubMed Web of Science ®Google Scholar
• Elie B, Guiheneuc P. Sympathetic skin response: Normal results in different experimental conditions. Electroencephalogr Clin Neurophysiol 1990;76:258–267.
   PubMedGoogle Scholar
• Hilz MJ, Kolodny EH, Neuner I, Stemper B, Axelrod FB. Highly abnormal thermotests in familial dysautonomia suggest increased cardiac autonomic risk. J Neurol Neurosurg Psychiatr 1998;65:338–343.
   PubMedGoogle Scholar
• Bleustein CB, Arezzo JC, Eckholdt H, Melman A. The neuropathy of erectile dysfunction. Int J Impot Res 2002;14:433–439.
   PubMed Web of Science ®Google Scholar
• Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Cutaneous innervation in Guillain-Barré syndrome: Pathology and clinical correlations. Brain 2003;126:386–397.
   PubMed Web of Science ®Google Scholar
• Schüller TB, Hermann K, Baron R. Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small-fiber function in peripheral neuropathy. J Neurol 2000;247:267–272.
   PubMedGoogle Scholar